moniliformin has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawood, M; Efferth, T; Fleischer, E; Klauck, SM; Klinger, A; Lu, X; Shan, L; Sugimoto, Y; Yan, G | 1 |
1 other study(ies) available for moniliformin and Leukemia
| Article | Year |
|---|---|
A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells.
Topics: Animals; Apoptosis; Cell Survival; Cyclobutanes; Dose-Response Relationship, Drug; HCT116 Cells; HEK293 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leukemia; Molecular Docking Simulation; Mycotoxins; Protein Structure, Secondary; Protein Structure, Tertiary; Xenograft Model Antitumor Assays; Zebrafish | 2021 |